Detalles de la búsqueda
1.
A phase III study of BCD-055 compared with innovator infliximab in patients with active rheumatoid arthritis: 54-week results from the LIRA study.
Rheumatol Int
; 39(9): 1537-1546, 2019 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-31292709
2.
A randomised phase II study evaluating the efficacy and safety of subcutaneously administered ustekinumab and guselkumab in patients with active rheumatoid arthritis despite treatment with methotrexate.
Ann Rheum Dis
; 76(5): 831-839, 2017 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-28087506
3.
Maintenance, reduction, or withdrawal of etanercept after treatment with etanercept and methotrexate in patients with moderate rheumatoid arthritis (PRESERVE): a randomised controlled trial.
Lancet
; 381(9870): 918-29, 2013 Mar 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-23332236
4.
Restrictive IgG antibody response against mutated citrullinated vimentin predicts response to rituximab in patients with rheumatoid arthritis.
Arthritis Res Ther
; 17: 206, 2015 Aug 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-26268352
Resultados
1 -
4
de 4
1
Próxima >
>>